Ono Pharmaceutical Co Ltd
TSE:4528

Watchlist Manager
Ono Pharmaceutical Co Ltd Logo
Ono Pharmaceutical Co Ltd
TSE:4528
Watchlist
Price: 2 120 JPY 0.93% Market Closed
Updated: Aug 14, 2024
Have any thoughts about
Ono Pharmaceutical Co Ltd?
Write Note
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

502.7B
+0.9%
Revenue
Growth Rates:
1 Year
+12%
3 Years
+63%
5 Years
+74%
7 Years
+105%
10 Years
+251%
159.9B
-2%
Operating Income
Growth Rates:
1 Year
+7%
3 Years
+62%
5 Years
+153%
7 Years
+110%
10 Years
+505%
128B
+0.3%
Net Income
Growth Rates:
1 Year
+14%
3 Years
+70%
5 Years
+148%
7 Years
+129%
10 Years
+529%

Earnings Waterfall
Ono Pharmaceutical Co Ltd

Revenue
502.7B JPY
Cost of Revenue
-127.1B JPY
Gross Profit
375.5B JPY
Operating Expenses
-215.6B JPY
Operating Income
159.9B JPY
Other Expenses
-32B JPY
Net Income
128B JPY

Income Statement
Ono Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: JPY
Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024
Revenue
Revenue
143 247
N/A
137 756
-4%
134 888
-2%
139 090
+3%
135 775
-2%
139 663
+3%
143 698
+3%
140 928
-2%
160 284
+14%
183 346
+14%
207 707
+13%
236 710
+14%
244 797
+3%
246 953
+1%
248 517
+1%
256 523
+3%
261 836
+2%
272 166
+4%
284 787
+5%
284 464
0%
288 634
+1%
291 375
+1%
293 247
+1%
290 736
-1%
292 420
+1%
293 351
+0%
293 886
+0%
302 054
+3%
309 284
+2%
321 734
+4%
332 887
+3%
345 781
+4%
361 361
+5%
380 720
+5%
403 985
+6%
428 951
+6%
447 187
+4%
460 481
+3%
489 199
+6%
498 071
+2%
502 672
+1%
Gross Profit
Cost of Revenue
(32 746)
(33 216)
(33 988)
(34 362)
(35 136)
(36 062)
(36 996)
(38 363)
(41 524)
(48 498)
(55 196)
(61 811)
(65 524)
(64 462)
(63 788)
(65 491)
(65 391)
(70 396)
(76 528)
(81 748)
(83 829)
(84 414)
(83 869)
(78 792)
(79 063)
(78 896)
(79 155)
(83 659)
(85 573)
(87 809)
(89 380)
(90 056)
(93 511)
(97 649)
(101 656)
(106 664)
(110 062)
(113 296)
(121 115)
(121 737)
(127 126)
Gross Profit
110 501
N/A
104 540
-5%
100 900
-3%
104 728
+4%
100 639
-4%
103 601
+3%
106 702
+3%
102 565
-4%
118 760
+16%
134 848
+14%
152 511
+13%
174 899
+15%
179 273
+3%
182 491
+2%
184 729
+1%
191 032
+3%
196 445
+3%
201 770
+3%
208 259
+3%
202 716
-3%
204 805
+1%
206 961
+1%
209 378
+1%
211 944
+1%
213 357
+1%
214 455
+1%
214 731
+0%
218 395
+2%
223 711
+2%
233 925
+5%
243 507
+4%
255 725
+5%
267 850
+5%
283 071
+6%
302 329
+7%
322 287
+7%
337 125
+5%
347 185
+3%
368 084
+6%
376 334
+2%
375 546
0%
Operating Income
Operating Expenses
(84 072)
(85 454)
(86 486)
(87 415)
(85 845)
(79 910)
(80 530)
(81 920)
(88 370)
(98 770)
(106 272)
(113 413)
(103 170)
(113 176)
(115 792)
(119 860)
(138 495)
(137 381)
(139 212)
(142 077)
(141 496)
(142 951)
(140 642)
(136 036)
(135 905)
(129 902)
(126 717)
(124 760)
(125 226)
(132 846)
(139 407)
(157 417)
(157 286)
(171 506)
(177 035)
(178 669)
(187 365)
(202 036)
(209 355)
(212 335)
(215 611)
Selling, General & Administrative
(38 377)
(40 762)
(41 726)
(42 877)
(40 824)
(37 642)
(38 512)
(40 104)
(42 628)
(51 202)
(55 053)
(58 748)
(60 660)
(64 236)
(65 356)
(66 368)
(66 353)
(68 841)
(69 670)
(70 745)
(68 000)
(69 581)
(69 561)
(68 803)
(65 196)
(65 304)
(63 762)
(64 958)
(66 616)
(73 987)
(77 069)
(78 502)
(74 119)
(79 828)
(82 346)
(85 716)
(86 643)
(91 243)
(94 145)
(96 634)
(100 270)
Research & Development
(44 413)
(43 505)
(42 592)
(41 946)
(41 346)
(39 972)
(40 789)
(40 750)
0
(46 652)
(49 595)
(52 949)
(57 506)
(61 325)
(63 599)
(66 892)
(68 821)
(69 593)
(70 453)
(71 628)
(70 008)
(70 265)
(67 896)
(64 207)
(66 497)
(62 874)
(61 295)
0
(62 384)
(47 172)
(51 089)
(68 001)
(75 879)
(80 047)
(82 956)
(92 390)
(95 344)
(100 511)
(105 076)
(105 862)
(112 174)
Depreciation & Amortization
0
0
0
0
(1 398)
0
0
0
(1 351)
0
0
0
(1 389)
0
0
0
(1 702)
0
0
0
(2 033)
0
0
0
(2 483)
0
0
0
(2 614)
0
0
0
(2 938)
0
0
0
(2 843)
0
0
0
0
Other Operating Expenses
(1 282)
(1 187)
(2 168)
(2 592)
(2 277)
(2 296)
(1 229)
(1 066)
(44 391)
(916)
(1 624)
(1 716)
16 385
12 385
13 163
13 400
(1 619)
1 053
911
296
(1 455)
(3 105)
(3 185)
(3 026)
(1 729)
(1 724)
(1 660)
(59 802)
6 388
(11 687)
(11 249)
(10 914)
(4 350)
(11 631)
(11 733)
(563)
(2 535)
(10 282)
(10 134)
(9 839)
(3 167)
Operating Income
26 429
N/A
19 086
-28%
14 414
-24%
17 313
+20%
14 794
-15%
23 691
+60%
26 172
+10%
20 645
-21%
30 390
+47%
36 078
+19%
46 239
+28%
61 486
+33%
76 103
+24%
69 315
-9%
68 937
-1%
71 172
+3%
57 950
-19%
64 389
+11%
69 047
+7%
60 639
-12%
63 309
+4%
64 010
+1%
68 736
+7%
75 908
+10%
77 452
+2%
84 553
+9%
88 014
+4%
93 635
+6%
98 485
+5%
101 079
+3%
104 100
+3%
98 308
-6%
110 564
+12%
111 565
+1%
125 294
+12%
143 618
+15%
149 760
+4%
145 149
-3%
158 729
+9%
163 999
+3%
159 935
-2%
Pre-Tax Income
Interest Income Expense
3 035
2 861
3 098
3 233
3 511
3 864
3 342
2 976
2 779
2 233
2 256
2 866
2 278
2 775
2 869
2 509
3 252
3 165
3 399
3 184
3 152
2 895
2 525
2 681
2 232
2 248
2 310
2 028
2 374
2 311
2 348
2 275
1 487
1 698
1 520
1 438
1 563
1 724
3 085
2 450
3 799
Non-Reccuring Items
0
0
0
0
0
0
0
0
117
0
0
0
(3 819)
0
0
0
2 734
0
0
0
(1 299)
0
0
0
39
0
0
0
(10)
0
0
0
(7 124)
0
0
0
(7 797)
0
0
0
0
Total Other Income
0
(1)
0
2
0
0
(2)
(3)
(14)
(2)
0
1
(22)
1
0
(2)
(14)
(1)
(1)
0
(21)
4
5
5
(27)
6
4
4
41
(3)
0
(3)
98
(2)
(1)
(1)
6
(4)
(5)
(4)
0
Pre-Tax Income
29 464
N/A
21 946
-26%
17 512
-20%
20 548
+17%
18 305
-11%
27 555
+51%
29 512
+7%
23 618
-20%
33 272
+41%
38 309
+15%
48 495
+27%
64 353
+33%
74 540
+16%
72 091
-3%
71 806
0%
73 679
+3%
63 922
-13%
67 553
+6%
72 445
+7%
63 823
-12%
65 141
+2%
66 909
+3%
71 266
+7%
78 594
+10%
79 696
+1%
86 807
+9%
90 328
+4%
95 667
+6%
100 890
+5%
103 387
+2%
106 446
+3%
100 580
-6%
105 025
+4%
113 261
+8%
126 813
+12%
145 055
+14%
143 532
-1%
146 869
+2%
161 809
+10%
166 445
+3%
163 734
-2%
Net Income
Tax Provision
(8 922)
(6 475)
(5 227)
(4 214)
(5 089)
(7 814)
(7 722)
(6 944)
(8 080)
(8 894)
(12 054)
(15 862)
(18 504)
(17 955)
(17 672)
(18 686)
(13 525)
(13 710)
(14 453)
(11 754)
(13 462)
(14 099)
(15 554)
(18 145)
(19 808)
(21 768)
(23 468)
(21 227)
(25 392)
(25 315)
(24 503)
(26 948)
(24 340)
(27 156)
(30 020)
(33 212)
(30 619)
(31 667)
(36 819)
(38 750)
(35 694)
Income from Continuing Operations
20 542
15 471
12 285
16 334
13 216
19 741
21 790
16 674
25 192
29 415
36 441
48 491
56 036
54 136
54 134
54 993
50 397
53 843
57 992
52 069
51 679
52 810
55 712
60 449
59 888
65 039
66 860
74 440
75 498
78 072
81 943
73 632
80 685
86 105
96 793
111 843
112 913
115 202
124 990
127 695
128 040
Income to Minority Interest
(198)
(210)
(188)
(167)
(240)
(220)
(223)
(224)
(213)
(210)
(217)
(221)
(243)
(248)
(250)
(234)
(113)
(99)
(73)
(92)
(140)
(176)
(202)
(214)
(184)
(167)
(121)
(75)
(72)
(69)
(77)
(74)
(166)
(184)
(226)
(289)
(190)
(138)
(115)
(84)
(62)
Net Income (Common)
20 344
N/A
15 261
-25%
12 095
-21%
16 169
+34%
12 976
-20%
19 521
+50%
21 568
+10%
16 449
-24%
24 979
+52%
29 206
+17%
36 225
+24%
48 271
+33%
55 793
+16%
53 888
-3%
53 884
0%
54 759
+2%
50 284
-8%
53 745
+7%
57 919
+8%
51 978
-10%
51 539
-1%
52 633
+2%
55 510
+5%
60 235
+9%
59 704
-1%
64 872
+9%
66 739
+3%
74 364
+11%
75 425
+1%
78 003
+3%
81 866
+5%
73 558
-10%
80 519
+9%
85 922
+7%
96 568
+12%
111 555
+16%
112 723
+1%
115 064
+2%
124 875
+9%
127 610
+2%
127 977
+0%
EPS (Diluted)
38.38
N/A
28.79
-25%
22.82
-21%
30.51
+34%
24.48
-20%
36.83
+50%
40.7
+11%
31.04
-24%
47.13
+52%
55.11
+17%
68.35
+24%
91.07
+33%
105.26
+16%
102.06
-3%
104.42
+2%
106.53
+2%
96.99
-9%
104.56
+8%
112.68
+8%
101.08
-10%
100.24
-1%
102.61
+2%
110.2
+7%
120.44
+9%
118.45
-2%
129.95
+10%
133.67
+3%
148.95
+11%
151.09
+1%
156.25
+3%
163.99
+5%
147.78
-10%
162.16
+10%
175.95
+9%
197.75
+12%
228.44
+16%
230.82
+1%
235.61
+2%
258.04
+10%
268.18
+4%
266.59
-1%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 166,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.